NCT01668121View on ClinicalTrials.gov

Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Asthma
Interventions
DRUG

Symbicort Turbohaler

DRUG

Budesonide/formoterol Easyhaler

Trial Locations (1)

Unknown

PAREXEL International GmbH, Berlin

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT01668121 - Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers | Biotech Hunter | Biotech Hunter